Ondine Biomedical (LON:OBI) Trading Up 22.2% – Here’s Why

Ondine Biomedical Inc. (LON:OBI)’s share price shot up 22.2% during trading on Wednesday . The company traded as high as GBX 11.90 ($0.15) and last traded at GBX 11 ($0.13). 818,763 shares traded hands during trading, an increase of 206% from the average session volume of 267,427 shares. The stock had previously closed at GBX 9 ($0.11).

Ondine Biomedical Stock Performance

The stock has a market cap of £30.50 million, a PE ratio of -366.67 and a beta of 0.10. The company has a quick ratio of 8.26, a current ratio of 0.80 and a debt-to-equity ratio of 1,847.37. The stock has a 50-day moving average of GBX 8.33 and a 200 day moving average of GBX 7.65.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.